Christian Hengstenberg

Showing 1-8 of 8 articles

Transcatheter aortic valve implantation with the ACURATE neo valve: indications, procedural aspects and clinical outcomes

Kim W, Hengstenberg C, Hilker M, Schäfer U, Rudolph T, Toggweiler S, Rück A, Søndergaard L, Conradi L, Hamm C, Walther T, Möllmann H, Doss M, Holzamer A, Husser O, Belon C, Delaloye S

April 3, 2020 | 10.4244/EIJ-D-19-00908

Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr P, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M

February 20, 2020 | 10.4244/EIJ-D-19-00710

Interventions for valvular disease

Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry

Möllmann H, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala M, Toggweiler S, Kim W

February 2, 2018 | 10.4244/EIJ-D-17-00628

A new hope - low permanent pacemaker rates with self-expanding transcatheter heart valves

Hengstenberg C, Husser O

December 20, 2017 | 10.4244/EIJV13I11A196

Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI)

Ott I, Shivaraju A, Schafer N, Frangieh A, Michel J, Husser O, Hengstenberg C, Mayr P, Colleran R, Pellegrini C, Cassese S, Fusaro M, Schunkert H, Kastrati A, Kasel A

October 20, 2017 | 10.4244/EIJ-D-16-01036

Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study

Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner G, Antoni D, Kleber F-X, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B

December 20, 2015 | 10.4244/EIJY14M08_12

TRINITY heart valve prosthesis: a novel repositionable and retrievable transapical transcatheter aortic valve system

Hengstenberg C, Condado J, García D, Martinez M, La Forgia G, Ebner A, Gallo S, Silva E, Holzamer A, Husser O, Hilker M

March 20, 2015 | 10.4244/EIJY14M07_08

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site – CLOSURE device versus manual compression (ISAR-CLOSURE) trial

Xhepa E, Byrne R, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Bottiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz K, Kastrati A

June 20, 2014 | 10.4244/EIJV10I2A33

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease